Evonik expands North American contract development and manufacturing capabilities for advanced injectables
Evonik today announced a €35 million expansion of its contract development and manufacturing (CDMO) capabilities in North America to meet growing demand for controlled release injectable formulations.
The next generation of aircraft glazing: Evonik exhibits stretched PLEXIGLAS® in new record dimensions
With sizes of up to 3.7 by 5.4 meters, the sheets made of stretched polymethyl methacrylate (PMMA) are an unprecedented world novelty in the acrylic glass market.
The next generation of aircraft glazing: Evonik exhibits stretched ACRYLITE® in new record dimensions
With sizes of up to 3.7 by 5.4 meters, the sheets made of stretched polymethyl methacrylate (PMMA) are an unprecedented world novelty in the acrylic glass market.
PLEXIGLAS® molding compounds: New distributor for the Italian market
From July 1, 2018 the new distribution partner TER ITALIA, headquartered in Milan, will market the complete portfolio of Evonik’s PLEXIGLAS® and PLEXIMID® molding compounds in Italy.
A strong bond—plastic-rubber components without adhesives
LWB Steinl GmbH & Co.KG, Altdorf, and Evonik Industries, Essen, are combining their experience to manufacture a rotation-symmetrical plastic/rubber composite part.
Evonik Animal Nutrition Holds first Distributor Seminar Egypt
Egypt. Evonik Animal Nutrition held yesterday a seminar to promote Ecobiol® product range in Hurghda, Egypt in coordination with key local distributor, Egyptian Trading & Supplies (ETS).
Evonik is streamlining processes and reducing administrative and selling expenses
Evonik is reducing bureaucracy, streamlining processes, and cutting administrative and selling expenses. To achieve the target of permanently reducing the cost base by €200 million by the end of 2020
Evonik is streamlining processes and reducing administrative and selling expenses
Evonik is reducing bureaucracy, streamlining processes, and cutting administrative and selling expenses. To achieve the target of permanently reducing the cost base by €200 million by the end of 2020, management and employee representatives have agreed on key points.
